Report Detail
Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Professional Survey Report 2019
- RnM3747862 |
- 14 September, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
An angiotensin-converting-enzyme inhibitor (ACE inhibitor) is a pharmaceutical drug used primarily for the treatment of hypertension (elevated blood pressure) and congestive heart failure.
The global Angiotensin Converting Enzyme (ACE) Inhibitors market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Angiotensin Converting Enzyme (ACE) Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Angiotensin Converting Enzyme (ACE) Inhibitors market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Angiotensin Converting Enzyme (ACE) Inhibitors in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Angiotensin Converting Enzyme (ACE) Inhibitors manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Abbott Laboratories
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Sulfhydryl-containing Agents
Dicarboxylate-containing Agents
Phosphonate-containing Agents
Segment by Application
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other
Table of Contents
Executive Summary
1 Industry Overview of Angiotensin Converting Enzyme (ACE) Inhibitors
- 1.1 Definition of Angiotensin Converting Enzyme (ACE) Inhibitors
- 1.2 Angiotensin Converting Enzyme (ACE) Inhibitors Segment by Type
- 1.2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Sulfhydryl-containing Agents
- 1.2.3 Dicarboxylate-containing Agents
- 1.2.4 Phosphonate-containing Agents
- 1.3 Angiotensin Converting Enzyme (ACE) Inhibitors Segment by Applications
- 1.3.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hypertension
- 1.3.3 Cardiovascular Diseases
- 1.3.4 Kidney Diseases
- 1.3.5 Other
- 1.4 Global Angiotensin Converting Enzyme (ACE) Inhibitors Overall Market
- 1.4.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue (2014-2025)
- 1.4.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Production (2014-2025)
- 1.4.3 North America Angiotensin Converting Enzyme (ACE) Inhibitors Status and Prospect (2014-2025)
- 1.4.4 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Status and Prospect (2014-2025)
- 1.4.5 China Angiotensin Converting Enzyme (ACE) Inhibitors Status and Prospect (2014-2025)
- 1.4.6 Japan Angiotensin Converting Enzyme (ACE) Inhibitors Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Status and Prospect (2014-2025)
- 1.4.8 India Angiotensin Converting Enzyme (ACE) Inhibitors Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Angiotensin Converting Enzyme (ACE) Inhibitors
- 2.3 Manufacturing Process Analysis of Angiotensin Converting Enzyme (ACE) Inhibitors
- 2.4 Industry Chain Structure of Angiotensin Converting Enzyme (ACE) Inhibitors
3 Development and Manufacturing Plants Analysis of Angiotensin Converting Enzyme (ACE) Inhibitors
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Angiotensin Converting Enzyme (ACE) Inhibitors
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Angiotensin Converting Enzyme (ACE) Inhibitors Production and Capacity Analysis
- 4.2 Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Analysis
- 4.3 Angiotensin Converting Enzyme (ACE) Inhibitors Price Analysis
- 4.4 Market Concentration Degree
5 Angiotensin Converting Enzyme (ACE) Inhibitors Regional Market Analysis
- 5.1 Angiotensin Converting Enzyme (ACE) Inhibitors Production by Regions
- 5.1.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Production by Regions
- 5.1.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Regions
- 5.2 Angiotensin Converting Enzyme (ACE) Inhibitors Consumption by Regions
- 5.3 North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Analysis
- 5.3.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Production
- 5.3.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Angiotensin Converting Enzyme (ACE) Inhibitors Import and Export
- 5.4 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Analysis
- 5.4.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Production
- 5.4.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Import and Export
- 5.5 China Angiotensin Converting Enzyme (ACE) Inhibitors Market Analysis
- 5.5.1 China Angiotensin Converting Enzyme (ACE) Inhibitors Production
- 5.5.2 China Angiotensin Converting Enzyme (ACE) Inhibitors Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Angiotensin Converting Enzyme (ACE) Inhibitors Import and Export
- 5.6 Japan Angiotensin Converting Enzyme (ACE) Inhibitors Market Analysis
- 5.6.1 Japan Angiotensin Converting Enzyme (ACE) Inhibitors Production
- 5.6.2 Japan Angiotensin Converting Enzyme (ACE) Inhibitors Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Angiotensin Converting Enzyme (ACE) Inhibitors Import and Export
- 5.7 Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Market Analysis
- 5.7.1 Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Production
- 5.7.2 Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Import and Export
- 5.8 India Angiotensin Converting Enzyme (ACE) Inhibitors Market Analysis
- 5.8.1 India Angiotensin Converting Enzyme (ACE) Inhibitors Production
- 5.8.2 India Angiotensin Converting Enzyme (ACE) Inhibitors Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Angiotensin Converting Enzyme (ACE) Inhibitors Import and Export
6 Angiotensin Converting Enzyme (ACE) Inhibitors Segment Market Analysis (by Type)
- 6.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Production by Type
- 6.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type
- 6.3 Angiotensin Converting Enzyme (ACE) Inhibitors Price by Type
7 Angiotensin Converting Enzyme (ACE) Inhibitors Segment Market Analysis (by Application)
- 7.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Consumption by Application
- 7.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Consumption Market Share by Application (2014-2019)
8 Angiotensin Converting Enzyme (ACE) Inhibitors Major Manufacturers Analysis
- 8.1 Abbott Laboratories
- 8.1.1 Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Production Sites and Area Served
- 8.1.2 Abbott Laboratories Product Introduction, Application and Specification
- 8.1.3 Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Pfizer
- 8.2.1 Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Production Sites and Area Served
- 8.2.2 Pfizer Product Introduction, Application and Specification
- 8.2.3 Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Novartis
- 8.3.1 Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Production Sites and Area Served
- 8.3.2 Novartis Product Introduction, Application and Specification
- 8.3.3 Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Merck
- 8.4.1 Merck Angiotensin Converting Enzyme (ACE) Inhibitors Production Sites and Area Served
- 8.4.2 Merck Product Introduction, Application and Specification
- 8.4.3 Merck Angiotensin Converting Enzyme (ACE) Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Astra Zeneca
- 8.5.1 Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Production Sites and Area Served
- 8.5.2 Astra Zeneca Product Introduction, Application and Specification
- 8.5.3 Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Jhonson and Johnson
- 8.6.1 Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Production Sites and Area Served
- 8.6.2 Jhonson and Johnson Product Introduction, Application and Specification
- 8.6.3 Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Eli Lilly
- 8.7.1 Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Production Sites and Area Served
- 8.7.2 Eli Lilly Product Introduction, Application and Specification
- 8.7.3 Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Sanofi
- 8.8.1 Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Production Sites and Area Served
- 8.8.2 Sanofi Product Introduction, Application and Specification
- 8.8.3 Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Bristol-Myers Squibb
- 8.9.1 Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Production Sites and Area Served
- 8.9.2 Bristol-Myers Squibb Product Introduction, Application and Specification
- 8.9.3 Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Bayer
- 8.10.1 Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Production Sites and Area Served
- 8.10.2 Bayer Product Introduction, Application and Specification
- 8.10.3 Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 GSK
- 8.12 Teva Pharmaceutical
9 Development Trend of Analysis of Angiotensin Converting Enzyme (ACE) Inhibitors Market
- 9.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Trend Analysis
- 9.1.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Angiotensin Converting Enzyme (ACE) Inhibitors Regional Market Trend
- 9.2.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Forecast 2019-2025
- 9.2.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Forecast 2019-2025
- 9.2.3 China Angiotensin Converting Enzyme (ACE) Inhibitors Forecast 2019-2025
- 9.2.4 Japan Angiotensin Converting Enzyme (ACE) Inhibitors Forecast 2019-2025
- 9.2.5 Southeast Asia Angiotensin Converting Enzyme (ACE) Inhibitors Forecast 2019-2025
- 9.2.6 India Angiotensin Converting Enzyme (ACE) Inhibitors Forecast 2019-2025
- 9.3 Angiotensin Converting Enzyme (ACE) Inhibitors Market Trend (Product Type)
- 9.4 Angiotensin Converting Enzyme (ACE) Inhibitors Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Angiotensin Converting Enzyme (ACE) Inhibitors Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Angiotensin Converting Enzyme (ACE) Inhibitors. Industry analysis & Market Report on Angiotensin Converting Enzyme (ACE) Inhibitors is a syndicated market report, published as Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Angiotensin Converting Enzyme (ACE) Inhibitors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
